Uncategorized
Leqembi: Europe Checks It’s Safety; U.S. Approves Monthly Doses
The EMA has announced its schedule for reviewing the Alzheimer’s drug Leqembi (lecanemab) for use in Europe. Meanwhile, the U.S. FDA, which already approved the drug, is moving ahead with a new version that doses Leqembi in a better, more convenient fashion for those taking the drug over the long run.
Weight-loss Drug Ozempic Cuts Dementia Risk 48%
University of Oxford research revealed groundbreaking findings that could reshape dementia prevention. Ozempic (AKA Semaglutide/Wegovy), a type-2 diabetes and weight-loss drug, seems to significantly reduce the risk of dementia.
Making it Easier to Take Leqembi for Alzheimer’s
A drug for Alzheimer’s, called Leqembi, might soon be given less often. Right now, patients get it through a drip every two weeks. The idea is to change this to once a month.
Should People with Alzheimer’s Avoid Resveratrol?
While Resveratrol supplements decrease brain swelling, they increase brain shrinkage. Is the trade-off worthwhile?
Bezisterim: A New Way to Manage Methylation in Dementia
Bezisterim can manage inflammation and enhance energy transfer (insulin sensitivity) in the brain. Learn how it is in trials to improve memory and thinking in Alzheimer’s.
Carolyn Davis Talks About Her Leqembi Infusions
The newest and most promising drug to fight Alzheimer’s is Leqembi. Carolyn Davis is giving it a try. Learn about the promise, the risks and how it has restored her hope,
Brain Health Academy Launched by UsAgainstAlzheimer’s
Scheduled to begin on May 9, 2024, six new monthly sessions are now available in this free Continuing Education Program.
Ovary Removal During Hysterectomy: A Dementia Risk?
Removing ovaries with a hysterectomy might increase risk of heart disease, stroke and dementia.
How to Build a Professional Dementia Garden
The Therapeutic Gardens project in Italy has been studied, certified and recognized for excellence. Dementia patients improve memory, cognitive functions, language, mood and above all, they need less medication.
Recent Stories
Lecanemab’s Rare and Manageable Side Effects
Lecanemab is today’s #1 Alzheimer’s antibody. (Brand name: Leqembi) Washington University researchers found Lecanemab’s adverse events to be rare and manageable in very mild or mild Alzheimer’s.
Nanosilver Warning
Alzheimer’s is characterized by an overproduction of free radicals in cells. That’s why incredibly tiny “nanoparticles” of silver, found in supplements, cosmetics and food packaging, worry scientists. Hear their concerns, as well as products to avoid.
Magnesium’s Importance to Brain Health
DIET: MAGNESIUM appears to do more to maintain brain health, prevent cognitive impairment (CI), and fight Alzheimer’s Disease (AD), than previously thought. Learn how.
Most Popular Stories
85 with Dementia? Good Chance It’s HS-AGING, Not Alzheimer’s
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
A Grandchild for One Day Keeps Dementia Away
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
“I’ve Got You Under My Skin,” By Dad with Dementia & Son
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
Is Alzheimer’s Catchy?
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
Subscribe To Our Weekly Newsletter
No spam, only news and updates.
Books
Social Media
Categories
New Posts
Ten Ways to Get Alzheimer’s Patients to Bathe
Living in Awe Can Lower Alzheimer’s
